Search

Displaying results 6841 - 6850 of 6949 in total
  1. Drug

    Trabedersen

    go.drugbank.com/drugs/DB05697
    Investigational

  2. Drug

    DP-VPA

    go.drugbank.com/drugs/DB05821
    Investigational

    DP-VPA is D-Pharm's proprietary lipid modified version of valproic acid (VPA) that demonstrate that DP-VPA is well-tolerated in patients with resistant epilepsy and has a marked effect on reducing seizure frequency.

  3. Drug

    Tanomastat

    go.drugbank.com/drugs/DB06276
    Experimental

  4. Drug

    Pramiconazole

    go.drugbank.com/drugs/DB06295
    Experimental

  5. Drug

    LX-2931

    go.drugbank.com/drugs/DB06297
    Investigational

  6. Drug

    Ilodecakin

    go.drugbank.com/drugs/DB06449
    Investigational

  7. Drug

    Astaxanthin

    go.drugbank.com/drugs/DB06543
    Investigational

    Astaxanthin is a keto-carotenoid in the terpenes class of chemical compounds. It is classified as a xanthophyll but it is a carotenoid with no vitamin A activity. It is found in the majority of aquatic organisms with red pigment. Astaxan...

  8. Drug

    Bivatuzumab

    go.drugbank.com/drugs/DB06550
    Investigational

    Bivatuzumab (previously BIWA 4) is a humanized monoclonal antibody against CD44 v6.

  9. Drug

    Odiparcil

    go.drugbank.com/drugs/DB06609
    Investigational

  10. Drug

    Dexloxiglumide

    go.drugbank.com/drugs/DB04856
    Investigational

    Dexloxiglumide is a selective cholecystokinin type A (CCKA) receptor antagonist in phase III testing by Rottapharm in Europe only, as U.S. trials have been discontinued.